The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Depressive disorders—is it time to endorse different pathophysiologies?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 3×
“Alternatively, the group of patients with lower HAMD scores (and higher preferential somatodendritic 5-HT1A binding) may include patients with atypical depression, a reduced serotonin transmission but relatively unimpaired 5-HT1A autoreceptor function and hence a good response to treatment with SSRI (Santarelli et al.…”
BackgroundInfluentialThe Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
Sleep and Psychiatric Disorders: A Meta-analysis
Benca, R. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080059010 · Cited by 1,468
Gold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · cited 7×
“Some studies even noted an association between the extent of therapy-induced pro-inflammatory cytokine release and depressive symptoms (Bonaccorso et al., 2001; Musselman et al., 2001b).”
BackgroundResultInfluentialCytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999 · cited 3×
“…of SSRI to treat a depressive episode is influenced by gender (Kornstein et al., 2000a; Murck et al., 2003; Joyce et al., 2004) and thirdly, immune stimulation alters serotonin metabolism and availability of its precursor tryptophan (Maes et al., 1994; Capuron et al., 2002; Konsman et al., 2002).”
BackgroundThe Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0597 · Cited by 995 · cited 2×
“However, all studies taken together suggest that an acute depressive episode is primarily characterised by an acute phase immune response (Zorrilla et al., 2001), which can further impair corticosteroid-mediated negative feedback inhibition of the HPA axis (Schobitz et al., 1994).”
BackgroundStress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity
ELENKOV, I. J., & CHROUSOS, G. P. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04229.x · Cited by 983
A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat
Vertes, R. P. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903130409 · Cited by 842 · cited 3×
“Serotonergic neurons in the dorsal raphe nucleus, as well as noradrenergic neurons in the brainstem and the locus coeruleus are important afferents for the regulation of hypothalamic CRH secretion (Cunningham et al., 1990; Vertes, 1991; Valentino et al., 1993; Calogero, 1995; Dayas et al., 2001).”
BackgroundResultPet imaging of serotonin 1A receptor binding in depression
Drevets, W. C., Frank, E., Price, J. C., Kupfer, D. J., Holt, D., Greer, P. J., Huang, Y., Gautier, C., & Mathis, C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00189-4 · Cited by 666 · cited 2×
“In particular somatodendritic 5-HT1A receptor dysfunction, including decreased binding as well as impaired receptor signalling, in the afferent neurons of the raphe nuclei has been reported in patients with major depression (Drevets et al., 1999; Hsiung et al., 2003; Rabiner et al., 2004; Bhagwagar et al., 2004).”
BackgroundA neural circuit for circadian regulation of arousal
Aston-Jones, G., Chen, S., Zhu, Y., & Oshinsky, M. L. (2001) · Nature Neuroscience · doi:10.1038/89522 · Cited by 632 · cited 1×
“A reduced activity of the locus coeruleus, in turn, is a prerequisite for REM sleep and slow wave sleep (Aston-Jones et al., 2001).”
BackgroundMaes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622 · cited 1×
“…during a major depressive episode and a reduction of pro-inflammatory cytokine secretion with clinical improvement during antidepressant drug treatment (Maes et al., 1994, 1995; Rothermundt et al., 2001; Owen et al., 2001; Musselman et al., 2001b; Penninx et al., 2003; Thomas et al., 2005).”
BackgroundNeuroimaging Abnormalities in the Amygdala in Mood Disorders
DREVETS, W. C. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07098.x · Cited by 544
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000995 · Cited by 473 · cited 4×
“Moreover, cytokine therapies, used for treatment of hepatitis C and cancer, have been repeatedly associated with an enhanced incidence of depressive symptoms (Bonaccorso et al., 2001; Musselman et al., 2001b; Capuron et al., 2002; Schaefer et al., 2003; Capuron et al., 2003a).”
BackgroundInfluentialLicinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380 · cited 4×
“One mechanism through which pro-inflammatory cytokines, in particular IL-1b and IL-6, could contribute to depressive symptoms is via their stimulation of the HPA axis, including hypothalamic CRH secretion (Licinio and Wong, 1999; Leonard, 2001; Elenkov and Chrousos, 2002; Capuron and Dantzer, 2003).”
BackgroundInfluentialEffects of antidepressants on the production of cytokines
Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003164 · Cited by 370
Van Bockstaele, E. J., Colago, E. E. O., & Valentino, R. J. (1998) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1998.00254.x · Cited by 311
Capuron, L., Raison, C. L., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1342 · Cited by 308 · cited 4×
“As pro-inflammatory cytokines can reduce serotonin levels as well as tryptophan availability by increasing the serotonin metabolism, it is intriguing that SSRI have been shown to reduce immunotherapyinduced depression (Musselman et al., 2001a; Capuron et al., 2003a).”
BackgroundResultInfluentialHolsboer, F., von Bardeleben, U., & Steiger, A. (2008) · Neuroendocrinology · doi:10.1159/000124986 · Cited by 255 · cited 2×
“Thus, CRH disturbs sleep continuity, promotes EEG activity in the higher frequency range and reduces slow wave sleep (Ehlers et al., 1986, 1997; Holsboer et al., 1988; Opp, 1995; Chang and Opp, 2001; Steiger, 2002).”
BackgroundSong, C., Lin, A., Bonaccorso, S., Heide, C., Verkerk, R., Kenis, G., Bosmans, E., Scharpe, S., Whelan, A., Cosyns, P., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00025-1 · Cited by 232
Klein, D. N., Schatzberg, A. F., McCullough, J. P., Dowling, F., Goodman, D., Howland, R. H., Markowitz, J. C., Smith, C., Thase, M. E., Rush, A. J., et al. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00020-8 · Cited by 212 · cited 1×
“A higher incidence of comorbid personality and anxiety disorders in earlyonset depression could also account for the more chronic course of the depressive episode in these patients (Fava et al., 1996; Klein et al., 1999; Kornstein et al., 2000b).”
BackgroundLow levels of circulating inflammatory cytokines—Do they affect human brain functions?
Pollmächer, T., Haack, M., Schuld, A., Reichenberg, A., & Yirmiya, R. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00004-1 · Cited by 202
Inflammatory markers in major depression and melancholia.
Rothermundt, M., Arolt, V., Peters, M., Gutbrodt, H., Fenker, J., Kersting, A., & Kirchner, H. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00157-9 · Cited by 174
Huitinga, I., Erkut, Z. A., van Beurden, D., & Swaab, D. F. (2004) · Annals of Neurology · doi:10.1002/ana.10766 · Cited by 126
Corticotropin-releasing hormone (CRH) as a regulator of waking
Chang, F.-C., & Opp, M. R. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00024-0 · Cited by 99 · cited 2×
“Thus, CRH disturbs sleep continuity, promotes EEG activity in the higher frequency range and reduces slow wave sleep (Ehlers et al., 1986, 1997; Holsboer et al., 1988; Opp, 1995; Chang and Opp, 2001; Steiger, 2002).”
BackgroundEffects of Sertraline on Sleep Architecture in Patients With Depression
Jindal, R. D., Friedman, E. S., Berman, S. R., Fasiczka, A. L., Howland, R. H., & Thase, M. E. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095345.32154.9a · Cited by 86
Neurotransmitter regulation of the hypothalamic corticotropin-releasing hormone neuron
CALOGERO, A. E. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44668.x · Cited by 53
Cited by
David, D. J., Samuels, B. A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., Drew, M., Craig, D. A., Guiard, B. P., Guilloux, J.-P., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.017 · Cited by 1,267
Self-citationSarris, J., Panossian, A., Schweitzer, I., Stough, C., & Scholey, A. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.04.002 · Cited by 469
Guilloux, J.-P., Seney, M., Edgar, N., & Sibille, E. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.01.019 · Cited by 360
Meta-review of depressive subtyping models
Harald, B., & Gordon, P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.015 · Cited by 328
Lamers, F., de Jonge, P., Nolen, W. A., Smit, J. H., Zitman, F. G., Beekman, A. T. F., & Penninx, B. W. J. H. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05398blu · Cited by 264
Metadata
- Authors
- Antonijevic, I. A.
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 31
- Issue
- 1
- Pages
- 1-15
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2091177850
- Cited by
- 210
- References
- 28
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.